| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.01 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.072 | 0.02 |